Supreme Court United in Deciding Isolated DNA Not Patentable

The Supreme Court Thursday dismissed Myriad Genetics’ patent-eligibility claims on the BRCA1 and BRCA2 genes commonly associated with breast and ovarian cancers, while upholding the company’s patents on the diagnostic technology it created from those genes.
Devices & Diagnostics Letter